Aspirin, but not propranolol, attenuates the acute stress-induced increase in circulating levels of interleukin-6: A randomized, double-blind, placebo-controlled study

Brain, Behavior, and Immunity

Volumn 22, Issue 2, 2008, Pages 150-157

  von Känel, Roland ^a,b   Kudielka, Brigitte M ^c   Metzenthin, Petra ^d   Helfricht, Susanne ^f   Preckel, Daniel ^f   Haeberli, André ^a   Stutz, Monika ^a   Fischer, Joachim E ^e  

^a UNIVERSITY OF BERN   (Switzerland)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF TRIER   (Germany)

^d BERN UNIVERSITY OF APPLIED SCIENCES   (Switzerland)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f ETH ZURICH   (Switzerland)

Author keywords

Cardiovascular disease; Cytokines; Drugs; Psychological stress

Indexed keywords

ACETYLSALICYLIC ACID; CYTOKINE; HYDROCORTISONE; INTERLEUKIN 6; PLACEBO; PROPRANOLOL DERIVATIVE;

ACUTE STRESS; ADULT; ANALYSIS OF COVARIANCE; ANALYSIS OF VARIANCE; ARITHMETIC; ARTICLE; ATHEROSCLEROSIS; BIVARIATE ANALYSIS; BLOOD SAMPLING; CIGARETTE SMOKING; CIRCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG INHIBITION; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MENTAL STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SOCIAL STRESS; THROMBOSIS; WAIST HIP RATIO;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-6; MALE; MIDDLE AGED; NEUROIMMUNOMODULATION; PLACEBOS; PROPRANOLOL; REST; STRESS, PSYCHOLOGICAL;

EID: 37349085797     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2007.07.005     Document Type: Article

References (41)

1. Aronson D., and Burger A.J. Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure. Ann. Noninvasive. Electrocardiol. 6 (2001) 98-106
2. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336 (1997) 1066-1071
3. Bayer Inc., 1999. Aspirin enteric coated. Antiplatelet therapy with acetylsalicylic acid. Leverkusen, Germany, p. 39.
4. Biasucci L.M., Liuzzo G., Colizzi C., and Maseri A. The role of cytokines in unstable angina. Expert. Opin. Investig. Drugs 7 (1998) 1667-1672
5. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., and Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. USA 100 (2003) 1920-1925
6. Black P.H. The inflammatory response is an integral part of the stress response: Implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain. Behav. Immun. 17 (2003) 350-364
7. Blake G.J., and Ridker P.M. Inflammatory bio-markers and cardiovascular risk prediction. J. Intern. Med. 252 (2002) 283-294
8. Brydon L., Edwards S., Mohamed-Ali V., and Steptoe A. Socioeconomic status and stress induced increases in interleukin-6. Brain. Behav. Immun. 18 (2004) 190-281
9. Dickerson S.S., and Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol. Bull. 130 (2004) 355-391
10. Edwards K.M., Burns V.E., Ring C., and Carroll D. Sex differences in the interleukin-6 response to acute psychological stress. Biol. Psychol. 71 (2006) 236-239
11. Gottlieb S.S., and McCarter R.J. Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction. Am. J. Cardiol. 87 (2001) 823-826
12. Haynes D.R., Wright P.F., Gadd S.J., Whitehouse M.W., and Vernon-Roberts B. Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolites?. Agents. Actions. 39 (1993) 49-58
13. Hennekens C.H., Sechenova O., Hollar D., and Serebruany V.L. Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions. J. Cardiovasc. Pharmacol. Ther. 11 (2006) 170-176
14. Herren T., Stricker H., Haeberli A., Do D.D., and Straub P.W. Fibrin formation and degradation in patients with arteriosclerotic disease. Circulation 90 (1994) 2679-2686
15. Ikonomidis L., Andreotti F., Economou E., Stefanadis C., Toutouzas P., and Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100 (1999) 793-798
16. Jenkins C.D., Stanton B.A., Niemcryk S.J., and Rose R.M. A scale for the estimation of sleep problems in clinical research. J. Clin. Epidemiol. 41 (1988) 313-321
17. Johnson J.D., Campisi J., Sharkey C.M., Kennedy S.L., Nickerson M., Greenwood B.N., and Fleshner M. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience. 135 (2005) 1295-1307
18. Kaplan J.R., Manuck S.B., Adams M.R., and Clarkson T.B. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation 76 (1987) 1364-1372
19. Kiecolt-Glaser J.C., Preacher K.J., MacCallum R.C., Atkinson C., Malarkey W.B., and Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. USA 100 (2003) 9090-9095
20. Kopp E., and Ghosh S. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265 (1994) 956-959
21. Kudielka B.M., Wüst S., Kirschbaum C., and Hellhammer D.H. Trier social stress test. In: Fink G. (Ed). Encyclopedia of Stress. second ed. (revised) (2007), Academic Press, Oxford
22. Kühlwein E.C., Irwin M.R., Ziegler M.G., Woods V.L., Kennedy B., and Mills P.J. Propranolol affects stress-induced leukocytosis and cellular adhesion molecule expression. Eur. J. Appl. Physiol. 86 (2001) 135-141
23. Mateos-Careres P.J., Garcia-Mendez A., Farre J., Sanchez de Miguel L., Gomez J., de Andres R., Rico L., Romero J., and Lopez-Farre A. Prior aspirin use in unstable angina patients with modified plasma inflammatory markers and endothelial nitric oxide synthase in neutrophils. Eur. J. Clin. Invest. 32 (2002) 895-900
24. Matsumura T., Tsushima K., Ohtaki E., Misu K., Tohbaru T., Asano R., Nagayama M., Kitahara K., Umemura J., Sumiyoshi T., and Hosoda S. Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy. J. Cardiol. 39 (2002) 253-257
25. Mehuys E., Vervaet C., Gielen I., Van Bree H., and Remon J.P. In vitro and in vivo evaluation of a matrix-in-cylinder system for sustained drug delivery. J. Control. Release 96 (2004) 261-271
26. Mittleman M.A., Maclure M., Sherwood J.B., Mulry R.P., Tofler G.H., Jacobs S.C., Friedman R., Benson H., and Muller J.E. Triggering of acute myocardial infarction onset by episodes of anger. Determinants of myocardial infarction onset study investigators. Circulation 92 (1995) 1720-1725
27. Morimoto A., Watanabe T., Morimoto K., Nakamori T., and Murakami N. Possible involvement of prostaglandins in psychological stress-induced responses in rats. J. Physiol. 443 (1991) 421-429
28. Papanicolaou D.A., Wilder R.L., Manolagas S.C., and Chrousos G.P. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 128 (1998) 127-137
29. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 316 (1998) 1236-1238
30. Ranjit N., Diez-Roux A.V., Shea S., Cushman M., Seeman T., Jackson S.A., and Ni H. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch. Intern. Med 167 (2007) 174-181
31. Rhind S.G., Gannon G.A., Shephard R.J., and Shek P.N. Indomethacin modulates circulating cytokine responses to strenuous exercise in humans. Cytokine 19 (2002) 153-158
32. Rozanski A., Blumenthal J.A., Davidson K.W., Saab P.G., and Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J. Am. Coll. Cardiol. 45 (2005) 637-651
33. Soszynski D., Kozak W., Conn C.A., Rudolph K., and Kluger M.J. Beta-adrenoceptor antagonists suppress elevation in body temperature and increase in plasma IL-6 in rats exposed to open field. Neuroendocrinology. 63 (1996) 459-467
34. Steptoe A., Willemsen G., Owen N., Flower L., and Mohamed-Ali V. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clin. Sci. 101 (2001) 185-192
35. Steptoe, A., Hamer, M., Chida, Y., in press. The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis. Brain. Behav. Immun.
36. Vicennati V., Vottero A., Friedman C., and Papanicolaou D.D. Hormonal regulation of interluekin-6 production in human adipocytes. Int. J. Obes. Rel. Metab. Disord. 26 (2002) 905-911
37. von Känel R., Kudielka B.M., Preckel D., Hanebuth D., and Fischer J.E. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain. Behav. Immun. 20 (2006) 40-48
38. von Känel R., Dimsdale J.E., Mills P.J., Ancoli-Israel S., Patterson T.L., Mausbach B.T., and Grant I. Effect of Alzheimer caregiving stress and age on frailty markers interleukin-6, C-reactive protein, and D-dimer. J. Gerontol. A. Biol. Sci. Med. Sci. 61 (2006) 963-969
39. Westermann J., Demir A., and Herbst V. Determination of cortisol in saliva and serum by a luminescence-enhanced enzyme immunoassay. Clin. Lab. 50 (2004) 11-24
40. Williams J.A., and Schacter E. Regulation of macrophage cytokine production by prostaglandin E2. Distinct roles of cyclooxygenase-1 and cyclooxygenase-2. J. Biol. Chem. 272 (1997) 25693-25699
41. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214